Background: Androgen concentrations rise throughout gestation in the maternal and fetal circulations and may drive sex-specific differences in fetal growth. These sex-steroids function through the androgen receptor (AR) to transactivate genes primarily involved in growth pathways. Indeed, males grow normally compared to females in the presence of maternal asthma, regardless of whether this pathophysiology of pregnancy was controlled (inhaled corticosteroid use and no exacerbation of asthma) or not and we propose that altered expression of AR variants may confer growth differences by modulating the placenta's response to androgens.
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Methods: Placental protein and mRNA were used to identify AR protein variant levels and AR-downstream target gene expression, and were then analysed against neonatal measurements. Dihydrotestosterone (DHT)-induced AR protein variant expression and downstream growth factors were examined in vitro.
Results: Four known AR variants (AR-FL, AR-V1, AR-V7, and AR-45) and AR immunoreactive proteins at 120, 90, and 55 kDa were identified in human placentae. Male placentae from controlled asthmatic pregnancies had increased nuclear expression of AR-45 and decreased cytoplasmic and nuclear AR-V1 and AR-V7 expression. This increase in nuclear AR-45 expression was associated with increased IGF-1, IGF-1R, and IGFBP-5 mRNA expression. IGF-1R, IGFBP-3, and IGFB-5 mRNA was increased in male placentae from controlled asthmatic pregnancies. in vitro DHT stimulation increased AR-45 protein and IGF-1R and IGFBP-5 mRNA at 0.1 nM. No such changes were observed in females, regardless of asthma control or severity.
Conclusions: Our findings suggest that AR-45 is central in mediating placental androgen signalling in males, especially in the presence of controlled maternal asthma. Background: Our neonatal department adjusted our neonatal hypoglycaemia management. Pre change, breast feeding infants with a plasma glucose level (PGL) of 2.0-2.9 mmol/L were given glucose gel plus breast feeds. Our new guideline recommends infants with PGL 2.0-2.5 receive gel plus effective feed. Infants with PGL 2.6-2.9 have increased PGL surveillance but no gel administration. We assessed the effect of this change on subsequent hypoglycaemia.
MANAGEMENT OF BORDERLINE NEONATAL
Methods: Retrospective audit, reviewed 2 cohorts of inborn infants with PGL 2.6-2.9 from all infants born during one month pre-change and one month post-change of guideline using database analysis and clinical record review. Primary outcome was incidence of subsequent PGL <2.6. Infants already in our neonatal unit excluded.
Results: There were no significant differences in demographics, initial PGL, next PGL, or later episodes of hypoglycaemia. See table.
Conclusions: Cessation of glucose gel administration in infants with PGL 2.6-2.9 has not resulted in increased rates of hypoglycaemia among newborns. Background: Skin to skin care (SSC) soon after birth is a well-established practice in Australia with many benefits like mother-baby bonding, thermoregulation and promoting breast feeding. While majority of newborns tolerate it well, some may become compromised with serious consequences. Supervision for SSC in the first few hours after birth is crucial but also poses challenges to workload of midwifery staff in a busy birthing suite. A prior audit from our centre revealed only 21% compliance with paper-based observation chart for newborns in the immediate postpartum period.
Methods: As a part of this quality improvement activity, all babies receiving SSC had continuous pulse oximetery monitoring after birth for the first hour. Staff were trained with education sessions before and during implmentaion. Data was collected on staff attitudes, parent satisfaction surveys as well adverse events.
Results: Response rate to survey was 80% for Midwifery staff and 71% for mothers. Most midwifery staff received the practice positively and felt more reassured about the baby''s status. The survey identified gaps in maternal knowledge about risks and benefits of SSC. Overwhelming majority of staff recommended instituting this practice at other centres.
Conclusion: Continuous pulse oximetery in the first hours is a simple non-invasive and innovative approach to improve vigilance for all newborns receiving skin to skin care soon after birth. The success of this initiative lead to standard practice of two hours of continuous pulse oximetry momitoring for all babies at our institution and in the community midwifery program attending home births.
